Michel Detheux - 08 Aug 2024 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Executive Officer
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
08 Aug 2024
Net transactions value
$0
Form type
4
Filing time
09 Aug 2024, 20:00:02 UTC
Previous filing
08 Mar 2024
Next filing
11 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Gift $0 -442,800 -75% $0.000000 147,600 08 Aug 2024 Common Stock 442,800 $11.58 Direct F1, F2
transaction ITOS Stock Option (Right to Buy) Gift $0 +442,800 $0.000000 442,800 08 Aug 2024 Common Stock 442,800 $11.58 By MG3A F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person transferred this stock option to MG3A, a Belgian partnership of which the reporting person is the manager and the reporting person's spouse is the successor manager.
F2 This stock option vests over four years, with 25% vesting on March 7, 2025 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer.